N-PORT filing recap · October 2024
What did Davis New York Venture Fund buy in October 2024?
Reported stock-position changes between this filing and the previous one. These are Davis New York Venture Fund's own holdings, not the firm's.
Stock value
$6.56B
Positions
44
Estimated turnover
10.7%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
Davis New York Venture Fund opened positions in CVS Health and Trip.com Group while exiting Jd.com. It trimmed Meta Platforms, Berkshire Hathaway, Amazon, Chubb, Owens Corning, DBS Group, Bank of New York Mellon, Intel, and JPMorgan Chase. The fund substantially increased MGM Resorts International and Tourmaline Oil, and added to Markel Group and Agco.